Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company’s AlairTM Bronchial Thermoplasty System. Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European Respiratory Society (ERS) Congress in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/
Pet owner Judy Bernath loves her 11-year-old cat Billy, so when she noticed he had become lethargic, started losing weight and drastically changed from the happy cat he had once been, she made a visit to see her veterinarian Dr. David Bruyette, medical director at VCA West Los Angeles Animal Hospital. The VCA team diagnosed Billy as being hyperthyroid within a few days, and Dr. Bruyette shared conventional therapy options with Judy, like radiation therapy, daily pharmaceuticals and surgery. In addition, he discussed and ultimately recommended a new and different approach for Billy’s case – nutritional management.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51765-hills-pet-nutrition-launches-new-pet-food-for-hyperthyroid-cats
On June 5, CVS/pharmacy kicked-off its 10th annual in-store fundraising campaign -- “Researching a Cure” -- to support the fight against amyotrophic lateral sclerosis (ALS). Funds raised through the campaign benefit the ALS Therapy Alliance (ATA), a leading organization dedicated to advancing ALS research. Through the Researching a Cure campaign, CVS/pharmacy has raised more than $23 million in its stores and online at www.cvs.com, to fund new clinical research with the aim of discovering a treatment or cure for ALS. The 2011 campaign will run through June 25.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/50475/
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Is your dog a hero? American Humane Association’s Hero Dog Awards™ national search kicks off today at www.herodogawards.org.
The Film & Television Unit of American Humane Association is heading up the search for America’s Hero Dogs. Dogs may be nominated in eight categories: Law Enforcement and Arson Dogs; Service Dogs; Therapy Dogs; Military Dogs; Guide Dogs; Search and Rescue Dogs; Hearing Dogs; and Emerging Hero Dogs. Finalists in each category will be selected by the public from the pool of contestants, and the winners will be announced at the first-ever American Humane Association Hero Dog Awards™ celebrity gala, presented by CESAR® Canine Cuisine, at the Beverly Hilton Hotel in Los Angeles, California on October 1, 2011.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/americanhumane/49289/
Imagine your world in silence. Imagine the colour and vibrancy of your world sapped and living in silence. Imagine without communication how your world would be colourless, and you would feel boxed in, unable to communicate, share, grow. Your voice expresses who you are in the world, can you imagine losing your voice? Can you imagine your world in silence?
GivingvoiceUK and the giving voice campaign aim to secure access to speech and language therapy for all those who need it. Speech and language therapy means that people don't need to live in silence. No-one should have to live without speech; lend you support at http://www.givingvoiceuk.org/addyourvoice
http://acne.gd/clear-remedy/
I am glad I was in a position to attempt this item with a reduced cost, because frankly it did not reside up to its billing. The therapy system is according to salicylic acid and other
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
http://adultadhdtreatmentblog.com/adhd-alternative-treatment/
In recent years, study has brought to light some fairly startling details about using prescription medications to treat ADHD. For this reason, along with other people, many parents are now looking for ADHD alternative treatments for their children. Things like potentially serious side results, unknown long term effects and the increasing expenses of doctor prescribed medications are making an ADHD alternative therapy seem like a better idea each day. In this article, we
http://acne.gd/acne-kits-that-work-2/ You may have suffered acne breakouts as a teen, or you may be struggling with it presently.
You will find a lot of alternative choices for this common skin condition, you just have to know which therapy will work greatest for you.
CVS/pharmacy has kicked-off its ninth annual in-store fund raising campaign to support the fight against amyotrophic lateral sclerosis (ALS). Since 2002, CVS/pharmacy has partnered with the ALS Therapy Alliance (ATA) to help advance ALS research. To date, CVS/pharmacy has raised more than $19 million in its stores—a single $1 donation at a time—to support the funding of new clinical research with the aim of discovering a treatment or cure for this devastating disease. This year's campaign began on June 6 and runs through June 26.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/44466/
